Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
about
Blasts from the pastGlomerular Function and Structure in Living Donors: Lessons from Single Nephron StudiesTarget organ cross talk in cardiorenal syndrome: animal modelsMonitoring kidney function and albuminuria in patients with diabetes.Renal autoregulation in health and diseaseTherapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the ratRenoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expressionAngiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonistGene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulationChronic VEGF blockade worsens glomerular injury in the remnant kidney modelRenal nerves modulate renin gene expression in the developing rat kidney with ureteral obstructionIn response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathiesReduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in miceMechanisms underlying renoprotection during renin-angiotensin system blockade.Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trialTransient enalapril attenuates the reduction in glomerular filtration rate in prenatally programmed rats.ACE inhibitors in non-diabetic renal disease.Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseAngiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the ratGlomerular hypertrophy aggravates epithelial cell injury in nephrotic rats.Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.Lisinopril pharmacokinetics in chronic renal failureFive-sixth Nephrectomy in Female Common Marmosets(Callithrix jacchus) as a Chronic Renal Failure Model: -A Longitudinal Course of Serum Biochemical, Hematological and Histopathological Changes-.Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction.Exercise attenuates renal dysfunction with preservation of myocardial function in chronic kidney diseaseRegression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis.Ozone therapy on rats submitted to subtotal nephrectomy: role of antioxidant system.Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathies.Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architectureShear stress is normalized in glomerular capillaries following ⅚ nephrectomy.Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal diseaseBenign hyperfiltration after living kidney donationLongitudinal study of living kidney donor glomerular dynamics after nephrectomy.
P2860
Q24563415-6E9D8D83-7CC1-491D-8751-0F1195EC7A2CQ26752679-317BE443-0A30-450C-B848-7FE0733EB010Q26851343-7E048A08-E791-4F03-9D26-BAFFE70F5BC3Q27691297-01BA8F44-8353-4133-82F9-ACF2D1FF9894Q28082365-21B205FB-0177-4D52-9DE6-D87B406E8551Q28360398-79595694-AE9B-49C1-A2F9-C6071B3A1163Q28362709-EBA56CEF-03B7-49EF-876D-6C978CDDDA80Q28363381-9C8AA44B-1F55-46FE-ADA2-8890735BCA18Q28505894-6BE8F8B8-8A3C-4081-951B-2A90045BDFA4Q28728129-816E6D13-2798-40E5-A4B1-4133CCDB21F1Q30440531-1A36DE59-A31F-49EF-BDC7-FD3FC808C42BQ30445152-7B70FA2C-BCB4-48F5-B2A1-CEC9A4FDE130Q30448786-F66FD696-58A9-416D-908C-7B4439864739Q32032668-9D86B062-ABA8-48F7-A714-A9AC435E17F2Q33514216-01F8069B-FFE0-4D52-9272-663F2BAFE48CQ33612378-278A0FEA-5C35-42F2-8BEB-C9B381E4A4DFQ33614288-6A6D7AAD-D9DE-47A6-9D09-1042EDE889FBQ33652488-ACF509CD-E5C1-4325-9231-B89A6EDB2D39Q33727750-E211EAE3-1E37-4C47-AB66-DA85BDEE4DF4Q33794256-11A5F5E7-78FE-41DF-AAEB-E3FBBBFF411FQ34150690-ACBBBF0E-D767-406C-A198-DC0F34A4C919Q34243271-58E35896-A2D0-43F2-842F-C204A0CE5D84Q34247811-0BCCE436-2394-41BE-B29C-B03C38AB09BEQ34331403-24C8681A-5906-49FB-BF37-F18EFFD87866Q34417551-9324CC23-29AD-4908-80C0-FE28E83FAB3CQ34441164-C350B8F9-1F4D-4A56-9045-629B274533BFQ34475608-33986D89-C6DC-4DE1-8BFA-154E5FDDF2BEQ34526945-E491594D-B2D4-4AA7-AC72-0061DD445814Q34545813-627F7E68-45A6-4F53-84F0-63BAD7173D83Q34586027-FFE8C77C-9C1F-4F48-8646-71413E04B55EQ34595011-8BF8FB04-3B54-4855-BBB2-0A8E1FF5F4E5Q34817746-BCF52CD3-486C-4D87-99AA-022C2B7CF33CQ34894539-BB730B5E-2405-4A57-BD73-6B16AA2FC0A7Q34993934-AED1E76F-2E56-4492-82C4-84CD946F5BB3Q35013600-D8D402D0-D8E0-40D3-8268-796BA8A5957FQ35168038-86180B10-2367-4370-B21B-38ECC7F22BDFQ35178633-859301A3-F25C-4593-881C-596E57F10469Q35181081-4967F148-F631-44FF-B2DA-4E85879D3F62Q35183903-381900C5-5D3B-4DCE-B4B5-5436C3F31505Q35183906-8333F163-079F-4592-9949-24A072F24618
P2860
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass
description
1985 nî lūn-bûn
@nan
1985 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Control of glomerular hyperten ...... n rats with reduced renal mass
@ast
Control of glomerular hyperten ...... n rats with reduced renal mass
@en
Control of glomerular hyperten ...... n rats with reduced renal mass
@nl
type
label
Control of glomerular hyperten ...... n rats with reduced renal mass
@ast
Control of glomerular hyperten ...... n rats with reduced renal mass
@en
Control of glomerular hyperten ...... n rats with reduced renal mass
@nl
prefLabel
Control of glomerular hyperten ...... n rats with reduced renal mass
@ast
Control of glomerular hyperten ...... n rats with reduced renal mass
@en
Control of glomerular hyperten ...... n rats with reduced renal mass
@nl
P2093
P2860
P356
P1476
Control of glomerular hyperten ...... n rats with reduced renal mass
@en
P2093
B M Brenner
H G Rennke
S Anderson
P2860
P356
10.1172/JCI112013
P407
P577
1985-08-01T00:00:00Z